Free Trial
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Q2 2025 Earnings Report

Fresenius Medical Care AG & Co. KGaA logo
$25.11 -0.23 (-0.91%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$25.12 +0.01 (+0.04%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fresenius Medical Care AG & Co. KGaA EPS Results

Actual EPS
N/A
Consensus EPS
$0.47
Beat/Miss
N/A
One Year Ago EPS
N/A

Fresenius Medical Care AG & Co. KGaA Revenue Results

Actual Revenue
N/A
Expected Revenue
$5.00 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fresenius Medical Care AG & Co. KGaA Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Fresenius Medical Care AG & Co. KGaA Earnings Headlines

This rock I’m holding could be worth trillions
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.
See More Fresenius Medical Care AG & Co. KGaA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius Medical Care AG & Co. KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius Medical Care AG & Co. KGaA and other key companies, straight to your email.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

View Fresenius Medical Care AG & Co. KGaA Profile

More Earnings Resources from MarketBeat